Detalhe da pesquisa
1.
The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.
PLoS Genet
; 15(10): e1008451, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31658259
2.
PIK3CA(H1047R) induces multipotency and multi-lineage mammary tumours.
Nature
; 525(7567): 114-8, 2015 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26266975
3.
ß-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.
Proc Natl Acad Sci U S A
; 114(5): E707-E716, 2017 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28096336
4.
The atypical cyclin-like protein Spy1 overrides p53-mediated tumour suppression and promotes susceptibility to breast tumourigenesis.
Breast Cancer Res
; 21(1): 140, 2019 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31829284
5.
Pathobiology of the 129:Stat1 -/- mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotype.
Breast Cancer Res
; 19(1): 102, 2017 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28865492
6.
Mice deficient in Rbm38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors.
Proc Natl Acad Sci U S A
; 111(52): 18637-42, 2014 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25512531
7.
The Trp53 delta proline (Trp53ΔP) mouse exhibits increased genome instability and susceptibility to radiation-induced, but not spontaneous, tumor development.
Mol Carcinog
; 55(9): 1387-96, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26310697
8.
Insights from transgenic mouse models of ERBB2-induced breast cancer.
Nat Rev Cancer
; 7(5): 389-97, 2007 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-17446858
9.
ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.
Proc Natl Acad Sci U S A
; 110(37): E3506-15, 2013 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23918374
10.
Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer.
Proc Natl Acad Sci U S A
; 110(14): E1301-10, 2013 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23509284
11.
Multipotent luminal mammary cancer stem cells model tumor heterogeneity.
Breast Cancer Res
; 17(1): 137, 2015 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26467658
12.
Introduction of Zinc-salt Fixation for Effective Detection of Immune Cell-related Markers by Immunohistochemistry.
Toxicol Pathol
; 43(6): 883-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26157038
13.
Diet-induced metabolic change induces estrogen-independent allometric mammary growth.
Proc Natl Acad Sci U S A
; 109(40): 16294-9, 2012 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22988119
14.
An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.
J Biol Chem
; 288(27): 19593-603, 2013 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23696648
15.
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.
Cancer Cell
; 10(5): 437-49, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17097565
16.
Nonlinear progression across the occult transition establishes cancer lethality.
bioRxiv
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712192
17.
Quantitation of fixative-induced morphologic and antigenic variation in mouse and human breast cancers.
Lab Invest
; 93(4): 480-97, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23399853
18.
The transcriptional repressor Snail promotes mammary tumor recurrence.
Cancer Cell
; 8(3): 197-209, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16169465
19.
Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
Breast Cancer Res
; 14(2): R67, 2012 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22531600
20.
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Breast Cancer Res
; 14(1): R16, 2012 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22264274